-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2020 to Q3 2025.
- Transcode Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$295K, a 89% decline year-over-year.
- Transcode Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$10.1M, a 3770% decline year-over-year.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was -$1.09M, a 225% decline from 2023.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $872K, a 18.4% decline from 2022.
- Transcode Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.07M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)